Continuous glucose monitors in healthy, non-diabetic people: what they actually show (and don’t)

Continuous glucose monitors (CGMs) have moved well beyond their original clinical purpose in diabetes management into mainstream wellness — worn by healthy people chasing "flat" glucose curves as a marker of metabolic optimisation. A randomized crossover trial specifically tested whether CGMs are even measuring something real and diet-responsive in healthy, non-diabetic people, which is a more basic question than it might seem.

What the trial confirmed

The trial found that diet-induced differences in estimated plasma glucose concentrations in healthy, non-diabetic adults were genuinely detectable by CGM — confirming the device does pick up real, meal-driven glucose variation in people without diabetes, not just noise. That is a meaningful validation: the tool is measuring something real in this population.

What it does not confirm

Detecting a real difference in glucose response between two diets is a different claim from that difference being clinically meaningful for a healthy person’s long-term health. Unlike in diabetes, where CGM data is tied to well-established outcomes (HbA1c, complication risk), there is no equally well-established outcome linking small glucose-curve variations in healthy people to hard endpoints like cardiovascular disease or mortality — that evidence base is still thin.

The context that gets lost in wellness marketing

Glucose naturally spikes after any carbohydrate-containing meal, and a "flat" curve is not automatically better if it comes at the cost of unnecessary anxiety about totally normal post-meal physiology, or restrictive eating that isn’t otherwise warranted. The device is real and the readings are real; the interpretation and the significance assigned to minor fluctuations in a metabolically healthy person is where the evidence gets much thinner than the marketing suggests.

Where CGMs clearly do add value for healthy adults

The clearest legitimate use case in non-diabetic people is comparative: testing your own response to specific meals or foods (a high-glycaemic breakfast versus a protein-forward one, for example) to make personalised, practical swaps — exactly the kind of diet-induced difference this trial confirms CGMs can detect reliably.

This is why Misi’s glucose-related guidance centres on the well-validated basics — fibre intake, post-meal walks, food order, HbA1c and fasting glucose trends — while treating a personal CGM experiment as an optional, useful add-on for curiosity and food-swap testing, not a required daily metric for someone without diabetes or prediabetes risk.